Loading...
XSHE
000972
Market cap368mUSD
Jul 09, Last price  
3.43CNY
1D
-1.15%
1Q
18.69%
Jan 2017
-51.00%
IPO
-21.50%
Name

Chalkis Health Industry Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
P/S
8.59
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
7.65%
Revenues
308m
-46.48%
1,030,318,9491,532,717,7532,142,790,1151,967,529,6281,660,020,9911,511,963,5701,424,785,5351,245,962,132954,944,330416,772,255682,896,707588,176,013517,710,604626,669,589213,188,82622,966,067174,451,612589,285,550575,779,449308,153,878
Net income
0k
-100.00%
48,715,418056,047,527027,774,8540064,021,480011,269,9420026,583,87104,975,7790026,085,146108,237,7770
CFO
0k
P
170,476,28165,019,714223,877,976144,722,3880000345,338,7290000416,334,994142,656,99500197,747,426-182,233,8930
Dividend
Jun 10, 20080.03 CNY/sh

Profile

Chalkis Health Industry Co., Ltd. produces, processes, and sells tomatoes worldwide. It offers tomato paste concentrated in drums and wooden bins, peeled and diced tomatoes, canned tomato products, tomato fiber sheets, and tomato seed oil, as well as lycopene capsules. The company was formerly known as Xinjiang Chalkis Co., Ltd. and changed its name to Chalkis Health Industry Co., Ltd. in May 2016. Chalkis Health Industry Co., Ltd. is based in Urumqi, China.
IPO date
Sep 26, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
308,154
-46.48%
575,779
-2.29%
589,286
237.79%
Cost of revenue
310,664
452,399
446,520
Unusual Expense (Income)
NOPBT
(2,510)
123,380
142,765
NOPBT Margin
21.43%
24.23%
Operating Taxes
264
219
5,291
Tax Rate
0.18%
3.71%
NOPAT
(2,774)
123,161
137,474
Net income
108,238
314.94%
26,085
 
Dividends
(16,468)
(12,913)
Dividend yield
0.60%
0.59%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
543,320
345,709
12,326
Long-term debt
75,754
72,891
Deferred revenue
92,167
16,900
2,405
Other long-term liabilities
29,874
125,665
Net debt
459,093
304,066
(195,145)
Cash flow
Cash from operating activities
(182,234)
197,747
CAPEX
(214,935)
Cash from investing activities
(216,704)
Cash from financing activities
183,087
322,245
FCF
(19,933)
(152,590)
123,303
Balance
Cash
159,980
110,646
207,472
Long term investments
2
3,888
1
Excess cash
144,573
85,745
178,007
Stockholders' equity
781,589
(898,625)
1,344,288
Invested Capital
579,172
1,543,193
45,514
ROIC
15.50%
106.69%
ROCE
19.14%
63.87%
EV
Common stock shares outstanding
771,284
773,127
771,284
Price
2.80
-21.13%
3.55
25.89%
2.82
4.83%
Market cap
2,159,594
-21.31%
2,744,601
26.19%
2,175,020
4.83%
EV
2,628,993
3,054,581
1,984,981
EBITDA
34,168
164,284
187,541
EV/EBITDA
76.94
18.59
10.58
Interest
26,837
22,072
15,870
Interest/NOPBT
17.89%
11.12%